Reaction profile
The FDA adverse-event record for haemorrhagic gastritis
26 FDA reports name haemorrhagic gastritis, a lower-volume reaction in the CVM extract (VeDDRA 1093). Plate stamps and neighbourhood peers follow.
- #2054 of 2,481
- by report volume (all reactions)
- 26
- reports citing this reaction
- 42.3%
- death-coded share
- Dog
- most-affected species
Release-over-release change
What changed in the latest FDA data snapshot
PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Haemorrhagic gastritis has 26 reports now versus 26 in that prior snapshot: 0 the same number of (0.0%).
- Report change
- +0
- Death-coded reports
- +0
- Death-coded share
- −0.0 pts
This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.
Subscribe to Haemorrhagic gastritis changesFDA AER · VeDDRA plate
Code 1093 VOL-TRACE
VOL-TRACE · DEATH-HOT · LOWER-Q · PHOTO-FINISH · SPECIES-DOG · DRUG-LEAD · DESK-WIDE · BOOK-FULL
- VOL-TRACE 26 reports
- DEATH-HOT 42.3%
- LOWER-Q #2054/2481
- PHOTO-FINISH Cushings disease - pi…
- SPECIES-DOG Dog · 23
- DRUG-LEAD Maropitant Citrate · 5
- DESK-WIDE 19 breeds
- BOOK-FULL 8/8 fields
Nearest volume peer: Cushings disease - pituitary dependent (±0 reports)
Upper-third death-coded share drives the outcome stamps on this plate; volume band, corpus rank, and co-report peers follow. Not a clinical diagnosis.
Lower-volume neighbourhood around Haemorrhagic gastritis
Lower-third volume poles plus nearest peers, not a full reaction corpus board reprint.
Haemorrhagic gastritis: high death-coded share in the FDA AER plate
Signature read: Haemorrhagic gastritis's 42.3% death-coded share is among the highest in the openFDA reaction corpus. Report volume is lower-third scale: 26 named reports in the openFDA extract. Death-coded share is upper-third: 11 of 26 reports (42.3% of named reports). Nearest volume peer: Cushings disease - pituitary dependent (±0 reports). Lead species Dog (23). Lead co-reported drug Maropitant Citrate (5).
Read these counts as reporting volume, not risk: per our methodology, A high death-coded share in FDA filings does not prove causation; co-reporting is voluntary temporal association only. Browse the full reactions index or the about page for how PlainBreed frames FDA CVM extracts.
Species Most Affected
Breeds Most Affected
Associated Drugs
What to do with this reaction
- Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
- Browse the full reaction directory to compare report counts across reaction types. All reactions
A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.
Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025
Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →